pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis

Published:2023-07 Issue: Volume:244 Page:125332
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Mahami Solmaz,Salehi Majid,Mehrabi Mohsen,Vahedi Hamid,Hassani Maryam Sadat,Bitaraf Fatemeh Sadat,Omri Abdelwahab

Funder

Shahroud University of Medical Sciences

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference79 articles.

1. Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature;Martin;Dig. Dis. Sci.,2015

2. Ulcerative colitis;Feuerstein;Mayo Clin. Proc.,2019

3. Ulcerative colitis as a progressive disease: the forgotten evidence;Torres;Inflamm. Bowel Dis.,2012

4. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies;Ng;Lancet.,2017

5. Epidemiology and risk factors for IBD;Ananthakrishnan;Nat. Rev. Gastroenterol. Hepatol.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments and new directions in the use of natural products for the treatment of inflammatory bowel disease;Phytomedicine;2024-09

2. Oxidative Stress-Induced Gastrointestinal Diseases: Biology and Nanomedicines—A Review;BioChem;2024-07-29

3. Bioinspired and bioderived nanomedicine for inflammatory bowel disease;WIREs Nanomedicine and Nanobiotechnology;2024-07

4. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis;International Journal of Pharmaceutics;2024-03

5. Nanoparticle-enhanced mesalazine therapy for inflammatory bowel disease;Pharmaceutical Science Advances;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3